Cardica to Announce Fiscal 2014 Fourth Quarter and Full Year Financial Results on Thursday, August 7, 2014

Cardica to Announce Fiscal 2014 Fourth Quarter and Full Year Financial Results                          on Thursday, August 7, 2014  PR Newswire  REDWOOD CITY, Calif., July 23, 2014  REDWOOD CITY, Calif., July 23, 2014 /PRNewswire/ --Cardica, Inc. (Nasdaq: CRDC) today announced that it will release financial results for its fiscal fourth quarter and year ended June 30, 2014, on Thursday, August 7, 2014, after the markets close. Cardica's management will host a conference call at 4:30 p.m. Eastern Time to discuss the financial results and provide an update on the company's business.  Conference Call Details To access the live conference call on August 7, 2014, at 4:30 p.m. Eastern Time via phone, please dial 866-953-6859 from the United States and Canada or 617-399-3483 internationally. The conference ID is 25697752. Please dial in approximately 10 minutes prior to the start of the call. A telephone replay will be available beginning approximately four hours after the call through August 14, 2014, and may be accessed by dialing 888-286-8010 from the United States and Canada or 617-801-6888 internationally. The replay passcode is 64477967.  To access the live and subsequently archived webcast of the conference call, go to the Investor Relations section of the company's website at www.cardica.com. Please connect to the website at least 15 minutes prior to the presentation to allow for any necessary software downloads.  The webcast is also being distributed through the Thomson StreetEvents Network. Individual investors can listen to the call at www.earnings.com, Thomson's individual investor portal, powered by StreetEvents. Institutional investors can access the call via Thomson StreetEvents at www.streetevents.com, a password-protected event management site.  About Cardica Cardicadesigns and manufactures proprietary stapling and anastomotic devices for laparoscopic and cardiac surgical procedures.Cardica's technology portfolio is intended to reduce operating time and facilitate minimally-invasive and robot-assisted surgeries. Cardica's MicroCutter XCHANGE^® 30, a cartridge-based articulating surgical stapling device with a five-millimeter shaft diameter, is manufactured and cleared for use in a variety of gastrointestinal procedures and appendectomies in the United States, and is marketed for a wide range of surgical procedures in Europe. Cardicais developing the Cardica^® MicroCutter XCHANGE^® 45, a cartridge-based microcutter device that is being designed with an eight-millimeter shaft to be used in a variety of procedures, including bariatric, colorectal, thoracic and general surgery. The Cardica MicroCutter XCHANGE 45 product requires 510(k) clearance and CE Mark before it may be sold in the United States and Europe, respectively, and is not yet commercially available in the U.S. or internationally. In addition, Cardica manufactures and markets its automated anastomosis systems, the C-Port^® Distal Anastomosis Systems and PAS-Port^® Proximal Anastomosis System for coronary artery bypass graft (CABG) surgery, and has shipped over 50,000 units throughout the world.  SOURCE Cardica, Inc.  Website: http://cardica.com Contact: Bob Newell, Vice President, Finance and Chief Financial Officer, (650) 331-7133, investors@cardica.com  
Press spacebar to pause and continue. Press esc to stop.